http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2578432-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dfab5f301614bf6b0ccb3611e98f4bd
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-534
filingDate 2015-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d452a278f50a29859d71ec52e487f45a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_683ccc84e82aeb152a4818e4646184c4
publicationDate 2016-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2578432-C1
titleOfInvention Method of obtaining a solid form of the drug sedative and antispasmodic action
abstract FIELD: pharmaceuticals. n SUBSTANCE: invention relates to the pharmaceutical industry, namely to a process for preparing a solid form of the drug sedative and antispasmodic action by creating a complex of beta-cyclodextrin with a mixture of ethyl ether of alpha-bromine-isovalerianic acid and peppermint oil (EBR-oil mixture). n EFFECT: drug obtained by the inventive process is stable. n 4 cl, 2 tbl, 11 ex
priorityDate 2015-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-021571-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2535020-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-83783-U
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2349334-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2157224-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19096565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430745574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID294739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415741165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID567820
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85597252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449603119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID294739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421045968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453837589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430865958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416014737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87186090

Total number of triples: 53.